VanEck Vectors Profile

Performance

   

Odds of Distress

23%23%
Check how we calculate scores
Equity ratings for VanEck Vectors Biotech ETF are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting June 24, 2019 and ending today August 23, 2019. Click here to learn more.
125.15
USD 0.66  0.52%

VanEck Vectors Summary

VanEck Vectors Biotech ETF [BBH] is traded in USA and was established 2011-12-20. The fund is classified under Health category within VanEck family. The entity is thematically classified as Healthcare Funds. VanEck Vectors Biotech currently have 365.43M in assets under management (AUM). , while the total return for the last 3 years was 3.49%.
Check VanEck Vectors Probability Of Bankruptcy

Geographic Allocation (%)

Top Etf Constituents

VanEck Vectors Target Price Odds Analysis

Odds Below 125.15HorizonTargetOdds Above 125.15
27.47%30 days 125.15 71.97%
Based on normal probability distribution, the odds of VanEck Vectors to move above current price in 30 days from now is about 71.97% (This VanEck Vectors Biotech ETF probability density function shows the probability of VanEck Vectors Etf to fall within a particular range of prices over 30 days) .

VanEck Vectors Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Jpmorgan Chase CoCall Options9.5 M243.4 M
Jpmorgan Chase CoPut Options1.3 M48.3 M
Ubs Group AgFund Units56.2 K7.2 M
View VanEck Vectors Diagnostics

VanEck Vectors Biotech Risk Profiles

VanEck Vectors Biotech Technical Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of thirty-nine. VanEck Vectors Biotech Price Movement is a mathematical transformation function to describe exponentially increasing price patterns. View also all equity analysis or get more info about exponential price movement math transform indicator.

VanEck Vectors Key Fundamentals

VanEck Vectors Against Markets

VanEck Vectors Vital Trading Data

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index. VanEck Vectors is traded on BATS Exchange in USA. more
NameVanEck Vectors Biotech ETF
ChairmanPhilip HornigView All
Thematic Classification
Currently Active Investing Idea
  Healthcare Funds
View All
Macroaxis Advice
InstrumentUSA Etf View All
RegionGlobal
Investment IssuerVan Eck
ExchangeBATS Exchange
Etf FamilyVanEck
Fund CategorySector
Portfolio ConcentrationHealth Care
BenchmarkDOW
Phone800 826 2333
CurrencyUSD - US Dollar
IssuerVan Eck
DescriptionVanEck Vectors Biotech ETF
Inception Date2011-12-20
BenchmarkMarket Vectors US Listed Biotech 25 Index
Entity TypeRegulated Investment Company
Asset Under Management351.34 Million
Average Trading Valume9,226.3
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionGlobal
AdministratorVan Eck Associates Corporation
AdvisorVan Eck Associates Corporation
CustodianThe Bank of New York Mellon Corporation
DistributorVan Eck Securities Corporation
Portfolio ManagerHao-Hung Peter Liao, Guo Hua Jason Jin
Transfer AgentThe Bank of New York Mellon Corporation
Fiscal Year End30-Sep
ExchangeNASDAQ
Number of Constituents28.0
Market MakerVirtu Financial
Total Expense0.39
Management Fee0.35
Nav Price125.63
Two Hundred Day Average125.37
Ytd13.94%
Average Daily Volume In Three Month15.23k
Fifty Two Week Low103.25
As Of DateJuly 31, 2019
Average Daily Volume Last 10 Day7.65k
Fifty Two Week High136.84
One Month-2.19%
Fifty Day Average126.09
Three Month2.33%
Check also Trending Equities. Please also try Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Search macroaxis.com